On Sunday, news wire PTI reported, citing government sources, that the company had agreed to bring down the price of ZyCov-D to ₹265 a dose...

According to sources, the government has negotiated the pricing of the vaccine which is "much lower than what the manufacturers had demande...

A panel of experts set up by the Indian government is looking into a Delta coronavirus subvariant that has been detected in the UK

The government had on Thursday said that the indigenously-developed, world's first DNA-based needle-free COVID-19 vaccine by Zydus Cadila w...

Needle-free ZyCoV-D, manufactured by Ahmedabad-based Zydus Cadila, is the first Covid-19 vaccine approved for the 12 to 18 years age group ...

The government said that 64.1 per cent doses of COVID-19 vaccine has been administered in vaccination centres in rural areas and 35 per cen...

The drug regulator had last week approved ZyCov-D, the world’s first DNA-based vaccine against the novel coronavirus, for emergency use in ...

The indigenously developed world's first DNA-based needle-free COVID-19 vaccine ZyCoV-D received Emergency Use Authorisation from the drug ...

Coronavirus cases in India dropped from a devastating peak in April and May, however, experts have warned of a third wave and reiterated th...

The company is expected to present phase III data for ZyCoV-D--a plasmid DNA vaccine—to the country’s drug regulatory authority by next wee...

Pharmaceutical major Zydus Cadila has told the Centre that it could apply for emergency use authorisation (EUA) for ZyCoV-D vaccine in the ...

From its initial mandate to identify priority development areas in biotechnology, it has been instrumental in creating an academic ecosyste...

The virus has killed nearly 100,000 Indians in May alone according to official figures, although experts say actual numbers are likely many...

The drug company is conducting phase-3 trials with over 20,000 participants to test whether its three-dose vaccine ZyCoV-D prevents virolog...

Pune-based vaccine major Serum Institute of India (SII) had entered into a collaboration with the University of Oxford and AstraZeneca to m...

The Phase-II study of the vaccine, ZyCoV-D, had been conducted in over 1,000 healthy adult volunteers as part of the adaptive Phase-I and I...

After his arrival at Ahmedabad airport from Delhi shortly after 9 am, Modi flew to the Zydus Cadila plant and held discussions with the pro...